SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000882104-16-000195
Filing Date
2016-09-13
Accepted
2016-09-13 16:21:54
Documents
5
Period of Report
2016-09-13
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A pdli-201609158xkadoc.htm 8-K/A 39927
2 CONSENT OF PRICEWATERHOUSECOOPERS AG pdli-201609158xkaex231.htm EX-23.1 4131
3 THE AUDITED SPECIAL PURPOSE FINANCIAL STATEMENTS pdli-201609158xkaex991.htm EX-99.1 80572
4 THE UNAUDITED SPECIAL PURPOSE INTERIM FINANCIAL STATEMENTS pdli-201609158xkaex992.htm EX-99.2 94230
5 UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AND STATEMENTS OF INCOME pdli-201609158xkaex993.htm EX-99.3 400620
  Complete submission text file 0000882104-16-000195.txt   620638
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19756 | Film No.: 161883043
SIC: 2836 Biological Products, (No Diagnostic Substances)